Semaglutide mimics a natural hormone called GLP-1, which helps control appetite and slows digestion
Alternative GLP-1 medications If tirzepatide specifically is not accessible, other GLP-1 receptor agonists provide meaningful weight loss and metabolic benefits, though the dual-agonist mechanism of tirzepatide gives it an edge in clinical data
Site rotation schedule Rotating injection sites prevents lipohypertrophy, a condition where repeated injections cause fatty tissue changes
Amazon Pharmacy kiosks have also been stocking the Wegovy pills since January
Here are the most common worries, and how we address them: *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)